The First Rapid Point of Care Test for Acute Respiratory Infections
FebriDx delivers results in 10 minutes — no lab required. Differentiate bacterial from viral infections at the point of care, enabling faster clinical decisions and smarter antibiotic stewardship.
Time to Result
10 min
Accuracy
97%
97%
Sensitivity for Bacterial Infections
10 min
Time to Result
2-in-1
Bacterial & Viral Detection
FDA
Cleared for Clinical Use
One Test. Two Answers. Immediate Action.
Clinical Benefits
FebriDx is the only rapid point-of-care test that simultaneously detects MxA (viral marker) and CRP (bacterial marker) from a single fingerstick blood sample
FebriDx is the only rapid point-of-care test that simultaneously detects MxA (viral marker) and CRP (bacterial marker) from a single fingerstick blood sample — giving clinicians the data they need to act in minutes, not hours.
Reduce unnecessary antibiotics.
Distinguish bacterial from viral infections with confidence, supporting responsible antibiotic stewardship programs.
No lab infrastructure needed.
Runs at the point of care — ED, urgent care, physician office — with no analyzer or specialized equipment.
Faster patient throughput.
10-minute results keep patients moving and reduce costly unnecessary admissions and extended workups.
Proven in peer-reviewed studies.
Validated in multiple clinical trials across hospital and outpatient settings with published sensitivity and specificity data.
How It Works
Simple. Fast. Clinically Actionable.
Collect Sample
A single fingerstick whole blood sample is all that's needed. No venipuncture, no centrifuge, no lab send-out.
Run the Test
Apply the sample to the FebriDx cassette. The lateral flow assay simultaneously measures MxA and CRP biomarkers.
Read the Result
Results are visually interpreted in 10 minutes. Bacterial, viral, or negative — clear, actionable data at the bedside.
Built for Healthcare Systems
Volume Pricing. Dedicated Support. Seamless Ordering.
Med Group1 is the authorized B2B distributor for FebriDx. We work directly with hospital systems, IDNs, and physician groups to structure bulk purchasing agreements that fit your procurement workflow.
Trusted by Healthcare Facilities Nationwide
Clinical Reference: FebriDx has been validated in peer-reviewed studies published in leading journals including The Journal of Infectious Diseases and BMC Infectious Diseases. Contact your Med Group1 account manager for full clinical dossier.
Ready to bring FebriDx to your facility?
Create your account today and get access to bulk pricing, dedicated support, and streamlined ordering.